@article{VortkampGesslerPaslieretal.1994,
  author    = {Vortkamp, Andrea and Gessler, Manfred and Paslier, D. Le and Elaswarapu, R. and Smith, S. and Grzeschik, Karl-Heinz},
  title     = {Isolation of a yeast artificial chromosome contig spanning the Greig cephalopolysyndactyly syndrome (GCPS) gene region},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-30182},
  year      = {1994},
  abstract  = {Disruption of the zinc finger gene GLI3 has been shown to be the cause of Greig cephalopolysyndactyly syndrome (GCPS), at least in some GCPS translocation patients. To characterize this genomic region on human chromosome 7p13, we have isolated a VAC contig of more than 1000 kb including the GLI3 gene. In this contig the gene itself spans at least 200-250 kb. A CpG island is located in the vicinity of the 5' region of the known GLI3 cDNA, implying a potential promoter region.},
  language  = {en}
}
@article{VortkampGesslerGrzeschik1991,
  author    = {Vortkamp, Andrea and Gessler, Manfred and Grzeschik, Karl-Heinz},
  title     = {GLI3 zinc-finger gene interrupted by translocations in Greig syndrome families},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-30100},
  year      = {1991},
  abstract  = {No abstract available},
  language  = {de}
}
@article{VortkampFranzGessleretal.1992,
  author    = {Vortkamp, Andrea and Franz, Thomas and Gessler, Manfred and Grzeschik, Karl-Heinz},
  title     = {Deletion of GLI3 supports the homology of the human Greig cephalopolysyndactyly syndrome (GCPS) and the mouse mutant extra toes (Xt)},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-30166},
  year      = {1992},
  abstract  = {No abstract available},
  language  = {en}
}
@article{VortkampThiasGessleretal.1991,
  author    = {Vortkamp, A. and Thias, U. and Gessler, Manfred and Rosenkranz, W. and Kroisel, P. M. and Tommerup, N. and Kruger, G. and Gotz, J. and Pelz, L. and Grzeschik, Karl-Heinz},
  title     = {A somatic cell hybrid panel and DNA probes for physical mapping of human chromosome 7p},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-59217},
  year      = {1991},
  abstract  = {No abstract available},
  subject      = {Biochemie},
  language  = {en}
}
@phdthesis{Vona2014,
  author    = {Vona, Barbara C.},
  title     = {Molecular Characterization of Genes Involved in Hearing Loss},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-112170},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2014},
  abstract  = {The auditory system is an exquisitely complex sensory organ dependent upon the synchronization of numerous processes for proper function. The molecular characterization of hereditary hearing loss is complicated by extreme genetic heterogeneity, wherein hundreds of genes dispersed genome-wide play a central and irreplaceable role in normal hearing function. The present study explores this area on a genome-wide and single gene basis for the detection of genetic mutations playing critical roles in human hearing. This work initiated with a high resolution SNP array study involving 109 individuals. A 6.9 Mb heterozygous deletion on chromosome 4q35.1q35.2 was identified in a syndromic patient that was in agreement with a chromosome 4q deletion syndrome diagnosis. A 99.9 kb heterozygous deletion of exons 58-64 in USH2A was identified in one patient. Two homozygous deletions and five heterozygous deletions in STRC (DFNB16) were also detected. The homozygous deletions alone were enough to resolve the hearing impairment in the two patients. A Sanger sequencing assay was developed to exclude a pseudogene with a high percentage sequence identity to STRC from the analysis, which further solved three of the six heterozygous deletion patients with the hemizygous, in silico predicted pathogenic mutations c.2726A>T (p.H909L), c.4918C>T (p.L1640F), and c.4402C>T (p.R1468X). A single patient who was copy neutral for STRC and without pathogenic copy number variations had compound heterozygous mutations [c. 2303_2313+1del12 (p.G768Vfs*77) and c.5125A>G (p.T1709A)] in STRC. It has been shown that STRC has been previously underestimated as a hearing loss gene. One additional patient is described who does not have pathogenic copy number variation but is the only affected member of his family having hearing loss with a paternally segregating translocation t(10;15)(q26.13;q21.1). Twenty-four patients without chromosomal aberrations and the above described patient with an USH2A heterozygous deletion were subjected to a targeted hearing loss gene next generation sequencing panel consisting of either 80 or 129 hearing-relevant genes. The patient having the USH2A heterozygous deletion also disclosed a second mutation in this gene [c.2276G>T (p.C759F)]. This compound heterozygous mutation is the most likely cause of hearing loss in this patient. Nine mutations in genes conferring autosomal dominant hearing loss [ACTG1 (DFNA20/26); CCDC50 (DFNA44); EYA4 (DFNA10); GRHL2 (DFNA28); MYH14 (DFNA4A); MYO6 (DFNA22); TCF21 and twice in MYO1A (DFNA48)] and four genes causing autosomal recessive hearing loss were detected [GJB2 (DFNB1A); MYO7A (DFNB2); MYO15A (DFNB3), and USH2A]. Nine normal hearing controls were also included. Statistical significance was achieved comparing controls and patients that revealed an excess of mutations in the hearing loss patients compared to the control group. The family with the GRHL2 c.1258-1G>A mutation is only the second family published worldwide with a mutation described in this gene to date, supporting the initial claim of this gene causing DFNA28 hearing loss. Audiogram analysis of five affected family members uncovered the progressive nature of DFNA28 hearing impairment. Regression analysis predicted the annual threshold deterioration in each of the five family members with multiple audiograms available over a number of years.},
  subject      = {Molekularbiologie},
  language  = {en}
}
@article{vonJagowSebald1980,
  author    = {von Jagow, Gerhard and Sebald, Walter},
  title     = {b-Type cytochromes},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-47383},
  year      = {1980},
  abstract  = {No abstract available},
  subject      = {Biochemie},
  language  = {en}
}
@article{VollmuthSchlickerGuoetal.2022,
  author    = {Vollmuth, Nadine and Schlicker, Lisa and Guo, Yongxia and Hovhannisyan, Pargev and Janaki-Raman, Sudha and Kurmasheva, Naziia and Schmitz, Werner and Schulze, Almut and Stelzner, Kathrin and Rajeeve, Karthika and Rudel, Thomas},
  title     = {c-Myc plays a key role in IFN-γ-induced persistence of Chlamydia trachomatis},
  series = {eLife},
  volume    = {11},
  journal   = {eLife},
  doi       = {10.7554/eLife.76721},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-301385},
  year      = {2022},
  abstract  = {Chlamydia trachomatis (Ctr) can persist over extended times within their host cell and thereby establish chronic infections. One of the major inducers of chlamydial persistence is interferon-gamma (IFN-γ) released by immune cells as a mechanism of immune defence. IFN-γ activates the catabolic depletion of L-tryptophan (Trp) via indoleamine-2,3-dioxygenase (IDO), resulting in persistent Ctr. Here, we show that IFN-γ induces the downregulation of c-Myc, the key regulator of host cell metabolism, in a STAT1-dependent manner. Expression of c-Myc rescued Ctr from IFN-γ-induced persistence in cell lines and human fallopian tube organoids. Trp concentrations control c-Myc levels most likely via the PI3K-GSK3β axis. Unbiased metabolic analysis revealed that Ctr infection reprograms the host cell tricarboxylic acid (TCA) cycle to support pyrimidine biosynthesis. Addition of TCA cycle intermediates or pyrimidine/purine nucleosides to infected cells rescued Ctr from IFN-γ-induced persistence. Thus, our results challenge the longstanding hypothesis of Trp depletion through IDO as the major mechanism of IFN-γ-induced metabolic immune defence and significantly extends the understanding of the role of IFN-γ as a broad modulator of host cell metabolism.},
  language  = {en}
}
@phdthesis{Vollmuth2021,
  author    = {Vollmuth, Nadine},
  title     = {Role of the proto-oncogene c-Myc in the development of Chlamydia trachomatis},
  doi       = {10.25972/OPUS-20365},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-203655},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2021},
  abstract  = {Chlamydia trachomatis, an obligate intracellular human pathogen, is the world's leading cause of infection related blindness and the most common, bacterial sexually transmitted disease. In order to establish an optimal replicative niche, the pathogen extensively interferes with the physiology of the host cell. Chlamydia switches in its complex developmental cycle between the infectious non-replicative elementary bodies (EBs) and the non-infectious replicative reticulate bodies (RBs). The transformation to RBs, shortly after entering a host cell, is a crucial process in infection to start chlamydial replication. Currently it is unknown how the transition from EBs to RBs is initiated. In this thesis, we could show that, in an axenic media approach, L glutamine uptake by the pathogen is crucial to initiate the EB to RB transition. L-glutamine is converted to amino acids which are used by the bacteria to synthesize peptidoglycan. Peptidoglycan inturn is believed to function in separating dividing Chlamydia. The glutamine metabolism is reprogrammed in infected cells in a c-Myc-dependent manner, in order to accomplish the increased requirement for L-glutamine. Upon a chlamydial infection, the proto-oncogene c-Myc gets upregulated to promote host cell glutaminolysis via glutaminase GLS1 and the L-glutamine transporter SLC1A5/ASCT2. Interference with this metabolic reprogramming leads to limited growth of C. trachomatis. Besides the active infection, Chlamydia can persist over a long period of time within the host cell whereby chronic and recurrent infections establish. C. trachomatis acquire a persistent state during an immune attack in response to elevated interferon-γ (IFN-γ) levels. It has been shown that IFN-γ activates the catabolic depletion of L-tryptophan via indoleamine 2,3-dioxygenase (IDO), resulting in the formation of non-infectious atypical chlamydial forms. In this thesis, we could show that IFN-γ depletes the key metabolic regulator c-Myc, which has been demonstrated to be a prerequisite for chlamydial development and growth, in a STAT1-dependent manner. Moreover, metabolic analyses revealed that the pathogen de routs the host cell TCA cycle to enrich pyrimidine biosynthesis. Supplementing pyrimidines or a-ketoglutarate helps the bacteria to partially overcome the persistent state. Together, the results indicate a central role of c-Myc induced host glutamine metabolism reprogramming and L-glutamine for the development of C. trachomatis, which may provide a basis for anti-infectious strategies. Furthermore, they challenge the longstanding hypothesis of L-tryptophan shortage as the sole reason for IFN-γ induced persistence and suggest a pivotal role of c-Myc in the control of the C. trachomatis dormancy.},
  language  = {en}
}
@phdthesis{Vollmar2008,
  author    = {Vollmar, Friederike Lara Veronika},
  title     = {Analyse der Kernh{\"u}llenbildung am Modellsystem Xenopus laevis},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-29298},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2008},
  abstract  = {Die Kernh{\"u}lle ist eine hoch spezialisierte Membran, die den eukaryotischen Zellkern umgibt. Sie besteht aus der {\"a}ußeren und der inneren Kernmembran, die {\"u}ber die Kernporenkomplexe miteinander verbunden werden. Die Kernh{\"u}lle reguliert nicht nur den Transport von Makromolek{\"u}len zwischen dem Nukleoplasma und dem Zytoplasma, sie dient auch der Verankerung des Chromatins und des Zytoskeletts. Durch diese Interaktionen hilft die Kernh{\"u}lle, den Zellkern innerhalb der Zelle und die Chromosomen innerhalb des Zellkerns zu positionieren, und reguliert dadurch die Expression bestimmter Gene. In h{\"o}heren Eukaryoten durchlaufen sowohl die Kernh{\"u}lle, als auch die Kernporenkomplexe w{\"a}hrend der Zellteilung strukturelle Ver{\"a}nderungen. Zu Beginn der Mitose werden sie abgebaut, um sich am Ende der Mitose in den Tochterzellen erneut zu bilden. Die molekularen Mechanismen, die zum Wiederaufbau der Kernh{\"u}lle f{\"u}hren, sind kaum gekl{\"a}rt. Ein geeignetes System, um bestimmte Ereignisse bei der Kernh{\"u}llenbildung zu untersuchen, liefert das zellfreie System aus Xenopus Eiern und Spermienchromatin (Lohka 1998). Es konnte bereits fr{\"u}her gezeigt werden, dass es im Eiextrakt von Xenopus laevis mindestens zwei verschiedene Vesikelpopulationen gibt, die zur Bildung der Kernh{\"u}lle beitragen. Eine der Vesikelpopulationen bindet an Chromatin, fusioniert dort und bildet eine Doppelmembran. Die andere Vesikelpopulation bindet an die bereits vorhandene Doppelmembran und sorgt f{\"u}r die Ausbildung der Kernporenkomplexe. Ziel dieser Arbeit war es, diese beiden Membranfraktionen zu isolieren und zu charakterisieren, wobei das Hauptinteresse in der porenbildenden Membranfraktion lag. Durch Zentrifugation {\"u}ber einen diskontinuierlichen Zuckergradienten konnten die Membranvesikel in zwei verschiedene Vesikelfraktionen aufgetrennt werden. Eine Membranfraktion konnte aus der 40\%igen Zuckerfraktion („40\% Membranfraktion") isoliert werden, die andere aus der 30\%igen Zuckerfraktion („30\% Membranfraktion"). Die verschiedenen Membranfraktionen wurden zu in vitro Kernen gegeben, in denen die Kernporen durch vorausgegangene Bildung von Annulate Lamellae depletiert worden waren. Nach Zugabe der 30\% Membranfraktion konnte die Bildung von funktionalen Kernporen beobachtet werden. Im Gegensatz dazu zeigte die 40\% Membranfraktion keine porenbildenden Eigenschaften. Unter Verwendung eines vereinfachten Systems, bestehend aus Zytosol, Spermienchromatin und den Membranen, wurde gezeigt, dass die 40\% Membranfraktion an Chromatin bindet und ausreichend ist, um eine kontinuierliche Doppelmembran ohne Kernporen zu bilden. Die 30\% Membranfraktion besitzt keine Chromatinbindungseigenschaften und wird aktiv entlang von Mikrotubuli zu den porenlosen Kernen transportiert. Dort interagiert sie mit der chromatingebundenen 40\% Membranfraktion und induziert die Porenbildung. Nach dem Vergleich der Proteinzusammensetzung der beiden Membranfraktionen, konnte das Major Vault Protein (MVP) nur in der porenbildenden Membranfraktion gefunden werden. MVP ist die Hauptstrukturkomponente der Vault-Komplexe, einem Ribonukleo-proteinpartikel, der in den meisten eukaryotischen Zellen vorhanden ist (Kedersha et al., 1991). Bemerkenswerterweise wird {\"u}ber die Funktion der Vault-Komplexe, trotz ihrer {\"u}biquit{\"a}ren Expression und ihrem Vorkommen in fast allen eukaryotischen Zellen, immer noch diskutiert. Um mehr {\"u}ber die Funktion und die Lokalisation der Vaults/MVP zu lernen, wurden die Vaults in Anlehnung an die Methode von Kedersha und Rome (1986) aus Xenopus Eiern isoliert. Zus{\"a}tzlich wurde rekombinantes Xenopus MVP hergestellt, das unter anderem f{\"u}r die Produktion von Antik{\"o}rpern in Meerschweinchen verwendet wurde. Um herauszufinden, ob die Anwesenheit von MVP in der 30\% Membranfraktion in direktem Zusammenhang mit deren porenbildender Eigenschaft steht, wurden gereinigte Vault-Komplexe oder rekombinantes MVP, das alleine ausreichend ist, um in sich zu den charakteristischen Vault-Strukturen zusammenzulagern, zu porenlosen Kernen gegeben. Sowohl gereinigte Vault-Komplexe, als auch rekombinantes MVP waren in der Lage in den porenlosen Kernen die Bildung von funktionalen Kernporen zu induzieren. Untersuchungen zur Lokalisation von MVP zeigten, dass MVP teilweise an der Kernh{\"u}lle und den Kernporenkomplexen lokalisiert, w{\"a}hrend der Großteil an MVP zytoplasmatisch vorliegt. Dies sind die ersten Daten, die Vaults/MVP mit der Kernporenbildung in Verbindung bringen. Deshalb bietet diese Arbeit die Grundlage, um diese unerwartete Rolle der Vaults in Zukunft genauer zu charakterisieren.},
  subject      = {Kernh{\"u}lle},
  language  = {de}
}
@article{VollandKauppSchmitzetal.2022,
  author    = {Volland, Julian Manuel and Kaupp, Johannes and Schmitz, Werner and W{\"u}nsch, Anna Chiara and Balint, Julia and M{\"o}llmann, Marc and El-Mesery, Mohamed and Frackmann, Kyra and Peter, Leslie and Hartmann, Stefan and K{\"u}bler, Alexander Christian and Seher, Axel},
  title     = {Mass spectrometric metabolic fingerprinting of 2-Deoxy-D-Glucose (2-DG)-induced inhibition of glycolysis and comparative analysis of methionine restriction versus glucose restriction under perfusion culture in the murine L929 model system},
  series = {International Journal of Molecular Sciences},
  volume    = {23},
  journal   = {International Journal of Molecular Sciences},
  number    = {16},
  issn      = {1422-0067},
  doi       = {10.3390/ijms23169220},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-286007},
  year      = {2022},
  abstract  = {All forms of restriction, from caloric to amino acid to glucose restriction, have been established in recent years as therapeutic options for various diseases, including cancer. However, usually there is no direct comparison between the different restriction forms. Additionally, many cell culture experiments take place under static conditions. In this work, we used a closed perfusion culture in murine L929 cells over a period of 7 days to compare methionine restriction (MetR) and glucose restriction (LowCarb) in the same system and analysed the metabolome by liquid chromatography mass spectrometry (LC-MS). In addition, we analysed the inhibition of glycolysis by 2-deoxy-D-glucose (2-DG) over a period of 72 h. 2-DG induced very fast a low-energy situation by a reduced glycolysis metabolite flow rate resulting in pyruvate, lactate, and ATP depletion. Under perfusion culture, both MetR and LowCarb were established on the metabolic level. Interestingly, over the period of 7 days, the metabolome of MetR and LowCarb showed more similarities than differences. This leads to the conclusion that the conditioned medium, in addition to the different restriction forms, substantially reprogramm the cells on the metabolic level.},
  language  = {en}
}